Type 2 diabetes: principles of pathogenesis and therapy.
about
MBX-102/JNJ39659100, a novel non-TZD selective partial PPAR-γ agonist lowers triglyceride independently of PPAR-α activationComplexity of type 2 diabetes mellitus data sets emerging from nutrigenomic research: a case for dimensionality reduction?Identification of a WD40 repeat-containing isoform of PHIP as a novel regulator of beta-cell growth and survivaltRNA methyltransferase homolog gene TRMT10A mutation in young onset diabetes and primary microcephaly in humansGenome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsTwelve type 2 diabetes susceptibility loci identified through large-scale association analysisHorror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cellsAntioxidants prevent health-promoting effects of physical exercise in humansA Molecular and Whole Body Insight of the Mechanisms Surrounding Glucose Disposal and Insulin Resistance with Hypoxic Treatment in Skeletal MuscleNeuroendorine and Epigentic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic SyndromeFishing for Nature's Hits: Establishment of the Zebrafish as a Model for Screening Antidiabetic Natural ProductsPrenatal Exposure to BPA and Offspring Outcomes: The Diabesogenic Behavior of BPAZinc and diabetes mellitus: understanding molecular mechanisms and clinical implicationsInhaled insulin: A "puff" than a "shot" before mealsPurinergic signalling and diabetesPostprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinideLifestyle therapy for the treatment of youth with type 2 diabetes(n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insightsAntidyslipidemic and Antioxidant Activities of Hibiscus rosa sinensis Root Extract in Alloxan Induced Diabetic RatsRegulatory Roles of MicroRNAs in DiabetesManagement of critically ill patients with type 2 diabetes: The need for personalised therapyA Metabolomic Approach to Understanding the Metabolic Link between Obesity and DiabetesEfficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozinCNC-bZIP protein Nrf1-dependent regulation of glucose-stimulated insulin secretionGenome-wide association study identifies multiple loci influencing human serum metabolite levelsGPR119 agonists for the treatment of type 2 diabetesLarge-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetesPharmacogenomics in diabetes mellitus: insights into drug action and drug discoveryMechanisms of disease: Ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptorsHigh-throughput screening for GPR119 modulators identifies a novel compound with anti-diabetic efficacy in db/db miceA pilot study to examine the correlation between cognition and blood biomarkers in a Singapore Chinese male cohort with type 2 diabetes mellitusCommon variants related to serum uric acid concentrations are associated with glucose metabolism and insulin secretion in a Chinese populationAngelica dahurica Extracts Improve Glucose Tolerance through the Activation of GPR119The PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese ratsThe diabetogenic effects of excessive ethanol: reducing beta-cell mass, decreasing phosphatidylinositol 3-kinase activity and GLUT-4 expression in ratsRevisiting the thrifty gene hypothesis via 65 loci associated with susceptibility to type 2 diabetesReplication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetesCommon variants in the type 2 diabetes KCNQ1 gene are associated with impairments in insulin secretion during hyperglycaemic glucose clampThe genetic effect of copy number variations on the risk of type 2 diabetes in a Korean population
P2860
Q21342745-47751282-A37F-4D6E-8AD1-32E1A588391DQ24289423-F73A537B-950E-4C2E-A01E-48D411DE6FE1Q24320317-9955C1BD-677E-456E-812C-986AFE62FC34Q24339464-860D7356-3CD9-443E-988F-D79303E03895Q24550675-60DD13D3-F49B-4E45-A764-393737CD2246Q24609915-F6824638-F5A5-4966-88C5-2FE3AFCF713AQ24631660-BA1CC7F9-C44E-476B-8C6D-D068C1C6ACC4Q24645027-AE3D217F-5881-420A-894B-1E23D27115BEQ24646248-E8CCC269-11B4-4CB6-8FAC-FA141EC3D58DQ26747591-2D6B4807-45EB-497C-8FFD-772DD46317F2Q26752744-BBC49F01-5BBF-461F-B34D-2406E9878C53Q26774936-BC6A0D6E-4ABB-41C7-BC98-C52E224B9706Q26775216-7645FE78-2518-44F5-B8A4-26BF5B9B3CD1Q26783573-8BD9E4A7-D510-4D5B-B2A0-097170179C08Q26796644-0D2C886E-A779-4451-9241-ECC8FCD71028Q26828574-0B030DA3-5895-4394-9B36-B6F4B7381C53Q26865976-92875E6F-4056-41B4-A251-B06D08EF6B70Q26995151-B443A41F-5E14-4352-A4B9-F5ED9F24C933Q27013554-0564A417-F00B-4E8F-8EEF-032DB89D450DQ27025395-A46B18FB-8613-4F32-B1F3-A91C36B103D4Q28069612-EB4C68C0-D632-4870-B08A-EFDF07BAC34DQ28081465-45B53C3F-B322-4F7E-82F4-8DE5915C8409Q28083355-CB49750F-64C4-4A45-B91A-3F4C2DB60444Q28250844-715D399F-44A7-44B2-AABC-E32732AFDF5AQ28254868-8E76EA37-E86E-49AC-B6CD-7DC68B28D5E1Q28258384-FE5D25D9-48C4-45C2-B99F-0DF66CAC40C5Q28259606-E9290AA3-8E87-45DD-AC4A-3D4BC8EA5277Q28272915-ECDE2D1D-4D0B-4410-AA80-FA641DADDFA8Q28274686-73E84F22-2340-4476-BA18-899580A5A4C4Q28277019-0213D44F-B4C6-4DCF-A542-A79F0799D2B5Q28533161-CA165F20-6AC3-4362-BFD1-18AE2A89329EQ28538677-0D800A17-BEFF-4A84-AC86-11F5F98487AFQ28543082-CC7D2DF7-3589-44A9-90A8-5DB0C7117282Q28552543-9B0B9922-87F1-47EB-AC7B-0811E62CEF05Q28574993-042D2258-0C3E-4C9B-8FFA-EF3827A15770Q28576337-7D9085E3-CC3D-46F9-A98D-1F72FCF48D3DQ28658911-49FF2718-1F2D-4277-88E8-1DF12746BDBFQ28680760-436B1D7E-4A6E-46F3-B57E-2FBB3E613F16Q28731529-364E6EDC-95AF-4769-B39D-B7436A76D66EQ28740836-A59F37F4-9461-4596-8021-89F1BE54E180
P2860
Type 2 diabetes: principles of pathogenesis and therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Type 2 diabetes: principles of pathogenesis and therapy.
@ast
Type 2 diabetes: principles of pathogenesis and therapy.
@en
type
label
Type 2 diabetes: principles of pathogenesis and therapy.
@ast
Type 2 diabetes: principles of pathogenesis and therapy.
@en
prefLabel
Type 2 diabetes: principles of pathogenesis and therapy.
@ast
Type 2 diabetes: principles of pathogenesis and therapy.
@en
P1433
P1476
Type 2 diabetes: principles of pathogenesis and therapy.
@en
P2093
Barry J Goldstein
Timon W van Haeften
P304
P356
10.1016/S0140-6736(05)61032-X
P407
P577
2005-04-01T00:00:00Z